The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The competent cells market size has grown rapidly in recent years. It will grow from $2.34 billion in 2023 to $2.65 billion in 2024 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be attributed to increasing demand for genetic cloning, increasing government funding for life sciences research, growth in the biotechnology workforce, increasing focus on rare disease research, and a rise in outsourcing research activities to contract research organizations. The competent cells market size is expected to see rapid growth in the next few years. It will grow to $4.39 billion in 2028 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, increasing investment in biotechnology startups, increasing demand for recombinant protein production, increasing prevalence of chronic diseases, and increasing demand for industrial biotechnology solutions. Major trends in the forecast period include technological advancements, artificial intelligence, quantum computing, 5G technology, and wearable technology.

The expanding biopharmaceutical industry is expected to fuel growth in the competent cells market in the coming years. This industry focuses on the development, production, and commercialization of drugs derived from biological sources, utilizing biotechnology and molecular biology to create innovative therapies and treatments. The biopharmaceutical sector is experiencing growth due to rapid advancements in biotechnology, rising demand for personalized medicine, and increasing investments in research and development aimed at innovative therapies. Competent cells are critical in this industry for applications such as genetic engineering, gene cloning, and protein expression, facilitating the production of recombinant proteins, therapeutic enzymes, and other biologics essential for drug development and production. For instance, the Department of Health and Social Care reported in May 2024 that the core biopharmaceutical sector generated £46.7 billion ($59.32 billion) in revenue in 2021/22, accounting for 43% of the entire life sciences industry. Additionally, according to AusBiotech, the biotechnology sector is projected to reach USD 5.66 billion (AU$8.67 billion) in aggregate revenues by 2024, reflecting a growth rate of 4.4%. Therefore, the burgeoning biopharmaceutical industry is a significant driver of growth in the competent cells market.

Get A Free Sample On The Competent Cells Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18540&type=smp

What Are The Key Trends That Influence Competent Cells Market Share Analysis?

Major companies in the competent cell market are developing innovative kits, such as replication competent lentivirus kits, to enhance the efficiency of genetic transformation processes and support cell and gene therapies. Cell and gene therapies are advanced medical treatments that involve modifying or utilizing cells or genes to treat or cure diseases. For instance, in February 2024, Bio-Rad Laboratories Inc., a US-based manufacturer of clinical diagnostics products, launched the vericheck ddPCR replication competent lentivirus kit and the vericheck ddPCR replication competent AAV kit. These kits employ advanced droplet digital PCR (ddPCR) technology to detect and quantify replication-competent lentivirus (RCL) and adeno-associated virus (AAV) with high sensitivity and precision. This capability is critical for ensuring the safety and efficacy of viral vectors used in therapeutic applications, as it aids in identifying and eliminating any potentially harmful replication-competent viruses.

Which Market Players Are Driving Growth In The Competent Cells Market?

Major companies operating in the competent cells market are Thermo Fisher Scientific Inc., Avantor Inc., Agilent Technologies Inc., Sigma-Aldrich, Bio-Rad Laboratories Inc., QIAGEN N.V., Promega Corporation, GenScript Biotech Corporation, Takara Bio Inc., New England Biolabs Inc., TransGen Biotech Co. Ltd., HiMedia Laboratories Pvt. Ltd., Zymo Research Corporation, Lucigen Corporation, Meridian Bioscience Inc., Codex DNA Inc., OriGene Technologies Inc., SERVA Electrophoresis GmbH, SMOBIO Technology Inc., Yeastern Biotech Co. Ltd., Scarab Genomics LLC, Enzynomics Co. Ltd., NZYTech Lda., Gold Biotechnology Inc., Abyntek Biopharma S.L

How Is The Global Competent Cells Market Segmented?

The competent cellsmarket covered in this report is segmented –

1) By Type: Chemically Competent Cells, Electrocompetent Cells, Ultracompetent Cells
2) By Application: Cloning, Protein Expression, Mutagenesis, Other Applications
3) By End User: Contract Research Organizations, Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Other End-Users

Read The Full Competent Cells Market Report Here

https://www.thebusinessresearchcompany.com/report/competent-cells-global-market-report

The Competent Cells Global Market Report 2024 provides an overview of the competent cellsmarket for the time series: historic years (2010 – 2021) and ten years forecast (2023 – 2032). The competent cells market forecast analyzes competent cells market size, competent cells market share, leading competitor and their market positions.

The Table Of Content For The Competent Cells Market Include

1. Competent Cells Market Executive Summary
2. Competent Cells Market Segments
3. Competent Cells Market Size And Template Market Growth Rate
4.  Key Competent Cells Market Trends
5. Major Competent Cells Market Drivers
……
25. Key Mergers And Acquisitions In The Competent Cells Market
26. Top Competent Cells Companies
27. Competent Cells Market Opportunities And Strategies
28. Competent Cells Market, Conclusions And Recommendations
29. Appendix

Explore Similar Reports From The Business Research Company:

Hydrogen Fuel Cells Market 2024

https://www.thebusinessresearchcompany.com/report/hydrogen-fuel-cells-global-market-report

Chimeric Antigen Receptor T (CAR-T) Cells Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/chimeric-antigen-receptor-t-car-t-cells-global-market-report

Circulating Tumor Cells Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model